A detailed history of Xtx Topco LTD transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 33,468 shares of RPTX stock, worth $40,161. This represents 0.01% of its overall portfolio holdings.

Number of Shares
33,468
Previous 33,320 0.44%
Holding current value
$40,161
Previous $109,000 5.5%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.75 - $3.99 $407 - $590
148 Added 0.44%
33,468 $115,000
Q2 2024

Aug 12, 2024

BUY
$3.02 - $4.7 $100,626 - $156,604
33,320 New
33,320 $109,000
Q2 2023

Aug 14, 2023

SELL
$8.63 - $12.53 $231,223 - $335,716
-26,793 Reduced 54.89%
22,021 $232,000
Q1 2023

May 12, 2023

BUY
$9.32 - $15.06 $222,235 - $359,105
23,845 Added 95.5%
48,814 $480,000
Q4 2022

Feb 14, 2023

BUY
$12.5 - $18.13 $312,112 - $452,687
24,969 New
24,969 $367,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $50.3M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.